基本情報
- 所属
- 自治医科大学 附属さいたま医療センター心血管治療部 教授 (心血管治療部長)(兼任)附属さいたま医療センター循環器内科 教授
- 学位
- 医学博士(自治医科大学)
- 研究者番号
- 20773310
- J-GLOBAL ID
- 201501004058346154
- Researcher ID
- AAK-4564-2020
- researchmap会員ID
- B000247981
研究キーワード
2研究分野
1学歴
1-
- 1999年3月
受賞
18論文
284-
Cardiovascular intervention and therapeutics 2024年12月11日Primary percutaneous coronary intervention (PCI) is the cornerstone of treatment for ST-segment elevation myocardial infarction (STEMI). Previous studies suggest that direct transport by ambulance to a primary PCI facility is associated with better clinical outcomes in patients with STEMI. However, those studies included seriously ill patients for whom direct transport is the only option. We included 462 patients with STEMI who were supposed to select either direct transport by ambulance or indirect transport via primary care doctor, and compared the clinical outcomes between the direct transfer group (n = 172) and the indirect transfer group (n = 290). The primary endpoint was major adverse cardiovascular events (MACE), which was defined as the composite of all-cause death, non-fatal myocardial infarction, re-admission for heart failure, and target vessel revascularization. The median follow-up duration was 540 days (86-1266 days). Age was significantly higher in the indirect transfer group [72.0 (64-80) years] than in the direct transfer group [69.5 (58.3-77) years] (p = 0.013). Onset to balloon time was significantly shorter in the direct transport group (p < 0.001). The Kaplan-Meier curves revealed that MACE were similarly observed between the two groups (31.4% vs. 27.2%; p = 0.330). After adjusting for potential confounders, indirect transfer was not associated with MACE (adjusted hazard ratio: 0.740, 95% confidence interval: 0.485-1.128, p = 0.161). In conclusion, indirect transfer was not associated with poor clinical outcomes in patients with STEMI who were supposed to select either direct transport or indirect transport.
-
Cardiovascular intervention and therapeutics 2024年12月3日The efficacy and safety of percutaneous coronary intervention (PCI) for coronary artery disease has been established, and approximately 250,000 PCI procedures are performed annually in Japan. However, various complications including life-threatening complications can occur during PCI. Although several bailout procedures have been proposed to address complications during PCI, it is critically important for operators to manage each complication in real catheter rooms with confidence even in emergent situations. Standard bailout methods including specific techniques should be clarified as algorithms and shared with inexperienced operators as well as experienced operators. The Task Force of the Japanese Society for Cardiovascular Intervention and Therapeutics (CVIT) has developed the expert consensus document on bailout algorithms for complications in PCI.
-
Internal medicine (Tokyo, Japan) 2024年9月4日Objective Triple-vessel disease (TVD) is a well-established prognostic factor for patients with acute myocardial infarction (AMI). However, there is a paucity of literature regarding the risk factors for in-hospital death in patients with non-ST-segment elevation myocardial infarction (NSTEMI) and TVD. In this retrospective study, we examined the determinants of in-hospital death in patients with NSTEMI and TVD who underwent percutaneous coronary intervention (PCI) for culprit lesions. Methods The primary objective of this study was to identify the factors associated with in-hospital death using a multivariate analysis. We included 253 patients with NSTEMI and TVD and divided them into a survivor group (n=239) and an in-hospital death group (n=14). Results Systolic blood pressure (SBP) at admission was significantly higher in the survivor group than in the in-hospital death group. The estimated glomerular filtration rate (eGFR) was also higher in the survivor group than in the in-hospital death group. In the multivariate logistic regression analysis, in-hospital death was inversely associated with the SBP at admission (odds ratio [OR] 0.984, 95% confidence interval [CI] 0.970-0.999, p<0.035) and eGFR (OR 0.966, 95% CI 0.939-0.994, p=0.019) and was associated with cardiopulmonary arrest (CPA) before PCI (OR 8.448, 95%CI 1.863-38.309, p=0.006). Conclusion In-hospital death was associated with CPA before PCI and inversely associated with the SBP at admission and eGFR in patients with NSTEMI and TVD who underwent PCI for the culprit lesion. It may be important to recognize these high-risk features in order to improve the clinical outcomes of patients with NSTEMI and TVD.
-
Journal of cardiology 2024年8月2日BACKGROUND: The clinical outcomes of ST-segment elevation myocardial infarction (STEMI) due to the occlusion of left coronary artery are worse in patients with proximal occlusion than in those with non-proximal occlusion. However, there are few reports that focus on the comparison of clinical outcomes in patients with STEMI between proximal and non-proximal right coronary artery (RCA) occlusions. METHODS: We included 356 patients with STEMI whose infarct-related artery is RCA and divided them into the proximal group (n = 129) and the non-proximal group (n = 227). We defined segment 1 of RCA as proximal, and segments 2, 3, and 4 as non-proximal according to the reporting system of the American Heart Association. The primary endpoint was major cardiovascular events (MACE), which was defined as the composite of all-cause death, non-fatal myocardial infarction, readmission for heart failure, and ischemia-driven target vessel revascularization. RESULTS: Incidence of shock at admission, requirement for catecholamine during percutaneous coronary intervention (PCI), or mechanical support during PCI tended to be higher in the proximal group (42.6 %) than in the non-proximal group (33.5 %) (p = 0.088). Although the incidence of right ventricular infarction tended to be higher in the proximal group (17.8 %) than in the non-proximal group (10.6 %) without reaching statistical significance (p = 0.072), the incidence of in-hospital death was similar between the 2 groups (1.6 % versus 1.8 %, p = 1.000). The MACE-free survival curves were not different between the 2 groups (p = 0.400). Multivariate Cox hazard analysis revealed that proximal RCA occlusion was not associated with MACE (HR 1.095, 95%CI 0.691-1.737, p = 0.699). CONCLUSIONS: Although the acute phase conditions such as shock or right ventricular infarction tended to be more severe in patients with proximal occlusion, overall clinical outcomes including long-term outcomes were comparable between the proximal and distal RCA occlusions. Furthermore, multivariate analysis showed that the proximal RCA occlusion was not associated with MACE after hospital discharge.
-
Heart and vessels 39(8) 665-672 2024年8月Killip classification has been used to stratify the risk of patients with acute myocardial infarction (AMI). There were many reports that Killip class 3 or 4 is closely associated with poor clinical outcomes. In other words, Killip class 1 or 2 is associated with favorable clinical outcomes in patients with AMI, especially when patients received primary percutaneous coronary intervention (PCI). However, some patients with Killip class 1/2 suffer from serious in-hospital complications. This study aimed to identify factors associated with serious in-hospital complications of ST-segment elevation myocardial infarction (STEMI) in patients with Killip class 1/2. The primary endpoint was serious in-hospital complications defined as the composite of in-hospital death and mechanical complications. We included 809 patients with STEMI, and divided them into the non-complication group (n = 791) and the complication group (n = 18). In-hospital death was observed in 14 patients (1.7%), and mechanical complications were observed in 4 patients (0.5%). Final TIMI flow ≤ 2 was more frequently observed in the complication group (33.3%) than in the non-complication group (5.4%) (p < 0.001). Multivariate logistic regression analysis revealed that serious in-hospital complication was associated with final TIMI flow grade ≤ 2 (Odds ratio 6.040, 95% confidence interval 2.042-17.870, p = 0.001). In conclusion, serious in-hospital complication of STEMI was associated with insufficient final TIMI flow grade in patients with Killip class 1/2. If final TIMI flow grade is suboptimal after primary PCI, we may recognize the potential risk of serious complications even when patients presented as Killip class 1/2.
MISC
33-
CIRCULATION 140 2019年11月0
-
EUROPEAN HEART JOURNAL 36 1002-1002 2015年8月
-
JOURNAL OF CARDIAC FAILURE 20(10) S168-S168 2014年10月
-
EUROPEAN HEART JOURNAL 35 1083-1083 2014年9月
-
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 64(11) B121-B121 2014年9月
-
JOURNAL OF CARDIOVASCULAR SURGERY 55(3) 307-323 2014年6月Peripheral artery disease (PAD) is an emerging problem especially with aging population and increase in the incidence of diabetes and metabolic syndrome. The disease is histologically characterized by the presence of moderate to severe calcification and fibrous plaques as compared to coronary and carotid atherosclerotic disease, which are richer in necrotic core. Endovascular therapy for the superficial femoral artery (SFA), at least in the United States, has been largely limited to balloon angioplasty and stenting and these are considered safe and relatively effective therapies. However, the patency rates remain low even at one year and restenosis is a growing and challenging problem. Recently the development of newer devices, i.e., drugeluting stent, and drug coated balloon are showing greater efficacy and are being adopted into daily practice. In this review, we will present the morphologic characteristics of the underlying SFA atherosclerotic disease and discuss in-stent restenosis and the mechanisms that may be involved in the induction of excessive smooth muscle cell proliferation and deposition of proteoglycans and collagen, that lead to restenosis.
-
EUROPEAN JOURNAL OF HEART FAILURE 16 292-292 2014年5月
-
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 63(12) A563-A563 2014年4月
-
HEART LUNG AND CIRCULATION 23(4) 387-387 2014年4月
-
JOURNAL OF CARDIAC FAILURE 19(10) S167-S167 2013年10月
-
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 62(18) B245-B246 2013年10月
-
診断と治療 100(10) 1593-1598 2012年10月
-
JOURNAL OF CARDIAC FAILURE 18(10) S163-S163 2012年10月
-
JOURNAL OF CARDIAC FAILURE 18(10) S172-S172 2012年10月
-
JOURNAL OF CARDIAC FAILURE 17(9) S175-S176 2011年9月
-
JOURNAL OF CARDIAC FAILURE 17(9) S159-S159 2011年9月
-
EUROPEAN HEART JOURNAL 32 572-572 2011年8月
-
AMERICAN JOURNAL OF CARDIOLOGY 107(8A) 35A-35A 2011年4月
-
JOURNAL OF CARDIAC FAILURE 16(9) S149-S149 2010年9月
-
EUROPEAN HEART JOURNAL 31 484-485 2010年9月
-
JOURNAL OF CARDIAC FAILURE 16(8) S17-S17 2010年8月
-
Circulation journal : official journal of the Japanese Circulation Society 73 471-471 2009年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 71 950-950 2007年10月20日
-
Circulation journal : official journal of the Japanese Circulation Society 71 865-865 2007年4月20日
-
Circulation journal : official journal of the Japanese Circulation Society 71 644-644 2007年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 70 435-435 2006年3月1日
-
AMERICAN JOURNAL OF HYPERTENSION 18(5) 259A-260A 2005年5月
-
Circulation journal : official journal of the Japanese Circulation Society 68 545-545 2004年3月1日
書籍等出版物
1共同研究・競争的資金等の研究課題
2-
日本学術振興会 科学研究費助成事業 基盤研究(C) 2022年4月 - 2026年3月
-
日本学術振興会 科学研究費助成事業 基盤研究(C) 2017年4月 - 2020年3月